Michael Chen to Reactive Oxygen Species
This is a "connection" page, showing publications Michael Chen has written about Reactive Oxygen Species.
Connection Strength
0.101
-
Wu CH, Bai LY, Tsai MH, Chu PC, Chiu CF, Chen MY, Chiu SJ, Chiang JH, Weng JR. Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy. Sci Rep. 2016 06 09; 6:27540.
Score: 0.033
-
Chiu CF, Bai LY, Kapuriya N, Peng SY, Wu CY, Sargeant AM, Chen MY, Weng JR. Antitumor effects of BI-D1870 on human oral squamous cell carcinoma. Cancer Chemother Pharmacol. 2014 Feb; 73(2):237-47.
Score: 0.028
-
Chang PY, Peng SF, Lee CY, Lu CC, Tsai SC, Shieh TM, Wu TS, Tu MG, Chen MY, Yang JS. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells. Int J Oncol. 2013 Oct; 43(4):1141-50.
Score: 0.027
-
Kosinska W, Pelle E, von Pressentin Md, Chen M, Guttenplan JB. Comparative mutagenicities of bleomycin and ferric-nitrilotriacetate in lacZ mice. Cancer Lett. 2002 Dec 10; 187(1-2):41-6.
Score: 0.013